Treatment and Care

This information sheet discusses the importance of bringing HIV and STD prevention programs into schools so adolescents can make healthy choices. It also provides information on CDC's Division of Adolescent and School Health (DASH). Topics include: Effective HIV/STD Prevention Education Programs; Youth Asset-Development Programs; CDC's Ongoing Efforts to Identify and Implement Effective HIV/STD Prevention Programs for Youth.

This information sheet discusses the importance of bringing HIV and STD prevention programs into schools so adolescents can make healthy choices. It also provides information on CDC's Division of Adolescent and School Health (DASH). Topics include: schools play a critical role in HIV and STD prevention; prevention programs can reduce risk behaviors; DASH promotes effective prevention through schools; National HIV/AIDS Strategy; and Dash's programs are data driven and evidence based.

This information sheet discusses the link between STDs and HIV. It explains how individuals with STDS have an increased susceptibility to HIV and individuals with HIV have increased infectiousness. The information sheet discusses how STD treatment can slow the spread of HIV and the implications for HIV and STD prevention programs. Information is provided for accessing the services of national health organizations.

This information sheet points out that the fungus Cryptococcus is the most common cause of meningitis in sub-Saharan Africa, and is a leading cause of death among people with HIV. Although it is not possible to prevent the initial infection with Cryptococcus, screening for cryptococcal antigen can detect disease before meningitis develops so treatment can begin and prevent death. A rapid, point-of-care dipstick test is now available for use in screening.

A checklist for individuals to see if they may need a test for TB. The checklist has 3 questions:

*Were you born in or have you lived in a country (for over a month) where TB is common? This includes anywhere in Africa, Asia, Mexico, Central or South America, the Caribbean or Eastern Europe.
*Have you lived with or spent time with someone who has had TB?
*Do you have HIV/AIDS, diabetes, or kidney disease? Are you an organ transplant recipient or do you take medication that weakens your immune system?

Basics of MDR-TB Clinical Care: Online Video Series is comprised of a series of short, online lectures presented in easy to digest segments. The series will cover major topics pertaining to epidemiology, diagnosis, treatment regimens, monitoring and case management, side-effects, prevention and isolation, treatment of contacts, and special situations. A distinguished group of experts from public health and academia contributed to the writing and recording of the finalized series. So far, three videos are available. More videos will be added later in 2018.

This internet file educates patients about hepatitis C treatment. It discusses the drugs approved for treatment of hepatitis C, why medications are used to treat the disease and how they are used, how likely it that the treatment will work, how the doctor monitors patients during treatment, side effects and how to cope with them, how patients can improve the chances of responding to treatment, why some patients take treatment and others do not, and where to get more information on the subject.

This information sheet discusses treatment for individuals with latent tuberculosis infection (LTBI), with the purpose of this treatment being the reduction of the risk that the infection will progress to TB disease. It explains how the health care provider determines whether the individual with a positive tuberculin skin test (TST) or blood test result is a candidate for treatment of LTBI and how the most effective regimen is chosen; presents LTBI treatment regimens; and describes monitoring during treatment, drug-drug interactions, particularly for HIV-infected patients, and side effects.

This information sheet is an agenda for providers who are taking a two-day training program in which they learn to serve persons at high risk for viral hepatitis. This material lists the training objectives and provides training modules, including specific modules targeted for substance use programs. The training can be used in substance use settings, STD/public health settings, HIV/AIDS programs, and correctional settings, as well as used for providers from all four target settings.

This monograph is a curricular outline for examination of an STD patient. It explains the rationale and general clinical approach including epidemiological and medical goals of an STD intervention, taking a sexual history, risk indicators for STD, chief complaint and history of present illness, past medical and STD history, gynecologic history, HIV risk assessment, social history, clinical management, and patient education.